UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$456M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$403M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$391M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$381M |
| 5 |
UnitedHealth
UNH
|
+$355M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$3.79B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$596M |
| 4 |
Johnson & Johnson
JNJ
|
+$307M |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$256M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.25% |
| 2 | Financials | 6.72% |
| 3 | Healthcare | 6.58% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4501
Vicor
VICR
$9.63B
| $739K | ﹤0.01% |
13,688
+4,774
| +54% | +$236K |
|
4502
Winmark
WINA
$1.36B
| $739K | ﹤0.01% |
2,223
+734
| +49% | +$249K |
|
4503
BioXcel Therapeutics
BTAI
$28.7M
| $739K | ﹤0.01% |
6,934
-3,084
| -31% | -$1.03M |
|
|
RDFN
4504
DELISTED
Redfin
RDFN
| $739K | ﹤0.01% |
59,486
+35,325
| +146% | +$344K |
|
|
CHUY
4505
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $738K | ﹤0.01% |
18,072
+4,191
| +30% | +$156K |
|
4506
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.06B
| $736K | ﹤0.01% |
13,056
-5,224
| -29% | -$259K |
|
|
SCS
4507
DELISTED
Steelcase
SCS
| $734K | ﹤0.01% |
95,259
+1,468
| +2% | +$11.1K |
|
4508
TriCo Bancshares
TCBK
$1.82B
| $733K | ﹤0.01% |
22,078
+169
| +0.8% | +$6.02K |
|
|
HAYN
4509
DELISTED
Haynes International, Inc.
HAYN
| $730K | ﹤0.01% |
14,367
+2,602
| +22% | +$124K |
|
4510
AMERISAFE
AMSF
$522M
| $730K | ﹤0.01% |
13,691
+5,648
| +70% | +$301K |
|
4511
NVE Corp
NVEC
$573M
| $730K | ﹤0.01% |
7,487
+3,831
| +105% | +$332K |
|
|
CHCT
4512
Community Healthcare Trust
CHCT
$433M
| $729K | ﹤0.01% |
22,086
+5,704
| +35% | +$198K |
|
|
RSVR
4513
Reservoir Media
RSVR
$656M
| $729K | ﹤0.01% |
121,018
+596
| +0.5% | +$3.77K |
|
4514
Arlo Technologies
ARLO
$1.6B
| $726K | ﹤0.01% |
66,515
+26,071
| +64% | +$212K |
|
|
EGRX
4515
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $725K | ﹤0.01% |
37,282
+26,563
| +248% | +$630K |
|
4516
Cimpress
CMPR
$2.29B
| $720K | ﹤0.01% |
12,104
+5,749
| +90% | +$283K |
|
4517
Banner Corp
BANR
$2.43B
| $719K | ﹤0.01% |
16,466
-3,205
| -16% | -$151K |
|
4518
iRadimed
IRMD
$1.15B
| $718K | ﹤0.01% |
15,038
+7,370
| +96% | +$332K |
|
4519
Ormat Technologies
ORA
$6.87B
| $716K | ﹤0.01% |
8,904
-12,942
| -59% | -$1.1M |
|
4520
Newmark Group
NMRK
$2.52B
| $716K | ﹤0.01% |
115,176
+38,502
| +50% | +$237K |
|
4521
AnaptysBio
ANAB
$1.64B
| $716K | ﹤0.01% |
35,197
+31,693
| +904% | +$643K |
|
4522
Invesco Next Gen Connectivity ETF
KNCT
$160M
| $715K | ﹤0.01% |
8,985
-194
| -2% | -$14.5K |
|
4523
German American Bancorp
GABC
$1.87B
| $714K | ﹤0.01% |
26,281
+11,610
| +79% | +$338K |
|
4524
Employers Holdings
EIG
$881M
| $713K | ﹤0.01% |
19,058
-10,010
| -34% | -$392K |
|
4525
West Bancorporation
WTBA
$484M
| $708K | ﹤0.01% |
38,454
+8,972
| +30% | +$156K |
|
Similar funds
UBS Group's Q2 2023 Portfolio in Review
As of Q2 2023, UBS Group held 10,482 positions worth $296B, up 8.2% from $274B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q2 2023 filing shows 945 new, 3,995 increased, 3,455 reduced and 1,657 closed positions. Its largest new stake was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M. The largest sale was UBS Group, an estimated $3.79B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M.
- UBS Group added most to State Street Financial Select Sector SPDR ETF in Q2 2023, an estimated $456M increase.
- UBS Group's biggest Q2 2023 reduction was UBS Group, cutting an estimated $3.79B.
- UBS Group fully exited DCP Midstream, LP in Q2 2023, selling an estimated $148M.
- UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q2 2023.
- UBS Group opened 945 new positions and closed 1,657 in Q2 2023.
- UBS Group's portfolio value rose 8.2% quarter-over-quarter to $296B.
Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.